Vascular Closure Devices

Vascular Closure Devices

Global Vascular Closure Devices Market to Reach US$1.4 Billion by 2030

The global market for Vascular Closure Devices estimated at US$875.2 Million in the year 2023, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Passive Approximators, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$996.3 Million by the end of the analysis period. Growth in the Active Approximators segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$361.3 Million While China is Forecast to Grow at 8.8% CAGR

The Vascular Closure Devices market in the U.S. is estimated at US$361.3 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$154.0 Million by the year 2030 trailing a CAGR of 8.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.0% CAGR.

Global Vascular Closure Devices Market - Key Trends & Drivers Summarized

What Are Vascular Closure Devices and How Do They Transform Patient Care?
Vascular closure devices (VCDs) are medical instruments used to seal puncture sites in arteries following cardiovascular procedures such as angiography or angioplasty. These devices offer a significant advancement over traditional manual compression methods, enhancing patient comfort and reducing the time required for hemostasis (the cessation of bleeding). VCDs fall into several categories, including collagen plugs, suture-based systems, and clip-based systems, each designed to provide rapid and reliable closure of arterial access sites. Their use minimizes the risk of complications such as bleeding and vascular injury, facilitating faster patient recovery and shorter hospital stays.

How Is Technological Innovation Impacting the VCD Market?
Technological advancements are at the forefront of driving innovations in the design and functionality of vascular closure devices. Recent developments include bioabsorbable materials that naturally dissolve in the body, reducing the risk of infection and other long-term complications associated with foreign objects left in the body. Additionally, advancements in device deployment mechanisms have led to more user-friendly designs that ensure more consistent and successful closures. Imaging technologies have also improved, aiding physicians in the accurate placement of VCDs, thereby increasing the efficacy and safety of procedures.

What Are the Clinical and Economic Benefits of Vascular Closure Devices?
From a clinical perspective, VCDs significantly enhance patient outcomes by reducing the incidence of complications associated with vascular access points. They enable immediate ambulation post-procedure, which is crucial for elderly patients or those with mobility issues. Economically, the use of VCDs can lead to cost savings for healthcare facilities by reducing the duration of post-procedure care and minimizing the need for additional staff during the recovery period. These devices also play a critical role in optimizing patient throughput in hospitals, allowing for the treatment of more patients and better utilization of resources.

What Drives the Growth in the Vascular Closure Devices Market?
The growth in the vascular closure devices market is driven by several factors, including the rising prevalence of cardiovascular diseases globally, which increases the demand for interventional procedures requiring VCDs. Technological advancements that enhance the safety and efficacy of these devices also contribute to market expansion. Additionally, the growing preference for minimally invasive surgeries among both patients and healthcare providers boosts the adoption of VCDs. The market is further supported by the increasing number of elderly populations, who are more prone to vascular diseases and benefit significantly from the quick recovery times associated with VCDs. Moreover, healthcare providers` emphasis on reducing procedure times and improving operational efficiencies continues to drive the adoption of advanced vascular closure technologies.

Select Competitors (Total 36 Featured) -

• Cardinal Health, Inc.
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• Teleflex, Inc.
• Cordis, a Cardinal Health company
• Merit Medical Systems, Inc.
• Elixir Medical Corporation
• Tricol Biomedical, Inc.
• Marine Polymer Technologies, Inc.
• Axio Biosolutions Private Limited
• Endocor GmbH

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.